维普期刊资源整合服务平台（V6.5）

183篇 您的检索式：作者名="WACHTEL E"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities显示文摘背景 WWOX 和 FHIT 是位于活跃易碎的地点,其损坏与乳癌的发展被联系了的二候选人肿瘤 suppressor 基因。这些基因的表达式和乳癌的开发的协会充分没被探索。我们与正常组织学的外观在胸织物评估了 mRNA 和 WWOX 和 FHIT 的蛋白质表示,不正常的 ductal 增生,在 situ 的 ductal 癌,并且看在表示的进步衰落是否是 present.Methods 颠倒抄写聚合酶链反应并且西方的弄污的侵略癌症被用来为 mRNA 和蛋白质表示评估标本包括有正常织物的 28 个标本,有不正常的 ductal 增生的 28 个标本,有 ductal 的 33 个标本汽车结果与相比在 situ 和侵略癌症标本,正常、不正常的增生标本有可检测的 mRNA 的更大的率(WWOX 率 ratio=2.95, 95% CI 1.24-7.08;FHIT 率 ratio=4.58, 95% Cl 1.82-11.81 ) 并且西方的弄污的可检测的蛋白质(WWOX 率 ratio=4.12, 95% Cl 1.63-10.73;FHIT 率 ratio=3.76, 95% Cl 1.44-10.06 ) 。为两蛋白质,正常、不正常的增生标本之间并且在之间的差别在 situ 和侵略的癌,标本碰巧是可解说的(P > 0.05 为每分析) 。在每个组织学的范畴以内,在标本的部分之中的差别显示出那 FHIT 和 WWOX mRNA。并且蛋白质表示碰巧是可解说的(P > 0.05 为每分析) FHIT 和 WWOX 的 .Conclusion 表示从正常组织学的外观与胸织物进步一起减少到不正常的 ductal 增生在 situ 癌症,并且最后的侵略癌症。	WANG Tian-tian Eldo E Frezza MA Rong HU San-yuan LIU Chong-zhong ZHANG Guang-yong Mitchell S. Wachtel LU Xiao-mei FENG Jin-bo LU Cui-xia	2008	Chinese Medical Journal2008，，20：	2
2	Micellar growth network formation and criticality in aqueous solutions of the non - ionic surfactant C12E5 显示文摘	BERNHEIM - CROSWASSER A WACHTEL E TALMON Y	2000	Langmuir2000，16，：	1
3	Left ventricular filling patterns inpatients with systemic hypertension and left ventricular hypertrophy(the LIFE study)显示文摘	Wachtell K Smith G Gerdts E	2007	Am J Cardiol2007，85，4：	1
4	Crural repair permits morbidly obese patients with not large hiatal hernia to choose laparoscopic adjustable banding as a bariatric surgical treatment显示文摘	Frezza E E Barton A Wachtel M S	2008	Obes Surg2008，18，5：	1
5	Angiotensin Ⅱ receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End Point Reduction in Hypertension ( LIFE ) Study 显示文摘	Wachtell K Lehto M C erdts E	2005	J Am Coll Cardiol2005，45，：	1
6	Angiotensin Ⅱ receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol:the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study显示文摘	Wachtell K LehtoM Gerdts E		0，，：	1
7	Left ventricular filling patterns inpatient s with systemic hypert ension and left ventricular hypertrophy (the LIFE study) 显示文摘	Wachtell K Smith G Gerdts E	2000	Am J Cardiol2000，85，4：	1
8	Angiotensin D receptor blockadereduces new-onset atrial fibrillation and subsequent stroke compared toatenolol : the Losartan Intervention For End Point Reduction in Hyper-tension ( LIFE) study显示文摘	Wachtell K Lehto M Gerdts E	2005	Am Coll Cardiol2005，45，5：	1
9	Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study显示文摘	Wachtell K Lehto M Gerdts E	2005	J Am Coll Cardiol2005，45，5：	1
10	Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol , the losartan intervention for end point reduction in hypertension (LIFE) study 显示文摘	Wachtell K Lehto M Gerdts E	2005	J Am Coll Cardiol2005，45，5：	1
11	Ansiotensin II repmr block- ade reduces new - onset atrial fibrillation and subsequent stroke compared to atenoloh the Los&rtan Intervention For End Point Reduction in Hypertension ( LIFE ) study 显示文摘	Wachtell K Lehto M Gents E	2005	J Am Coil Cardiol2005，45，5：	1
12	Changes in the physical state of membrane lipids during senescence of rose petals显示文摘	Faragher J D Wachtel E Mayak S	1987	Plant Physiology1987，83，：	1
13	Angiotensin Ⅱ receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the losartan intervention for end point reduction in hypertension (life) study显示文摘	WACHTELL K LEHTO M GERDTS E	2005	J Am Coil Cardiol2005，45，5：	1
14	Angiotensin Ⅱ receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolohthe losartan intervention for end point reduction in hypertension(LIFE) study显示文摘	Wachtell K Lehto M Gerdts E	2005	J Am Coll Cardiol2005，45，5：	1
15	Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study显示文摘	WACHTELL K LEHTO M GERDTS E	2005	J Am Coll Cardiol2005，45，：	1
16	Intreatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy:The LIFE Study显示文摘	Wachtell K Gerdts E Aurigemma GP	2010	Blood Press2010，19，3：	1
17	Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy ( the LIFE study ) 显示文摘	Wachtell K Smith G Gerdts E	2000	Am J Cardiol2000，85，4：	1
18	Building a bal- maced scorecard for a hum center显示文摘	WACHTEL T L HARFI'ORD C E HUGHOS J A	1999	Bums1999，25，5：	1
19	An H11 liquid crystal-based delivery system for cyclosporin A:physical characterization显示文摘	Libster D Aserin A Wachtel E	2007	J Colloid Interface Sci2007，308，：	1
20	Prognostic significance of left ventricular mass change during treatment of hypertension显示文摘	Devereux RB Wachtell K Gerdts E	2004	JAMA2004，292，：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示